We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Ozone Technology to Combat Hospital Infections

By HospiMedica staff writers
Posted on 02 Feb 2007
Advanced ozone technology is being trialed in hospitals to combat the growing threat of methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile, and other acquired infections in hospitals.

The portable ozone system will be used in hospital wards, operating rooms, and general areas when a threat of potential infection is identified. More...
The technology behind the system is based on advanced oxidation techniques that use naturally occurring elements to deliver a massive biocidal charge over a very short period of time--usually much less than an hour. After a short exposure time a quenching system quickly absorbs any remaining vapors, enabling the whole process to be completed in under an hour, leaving the room sanitized and completely free of any harmful chemical residuals.

The Steritrox (Stockport, UK) system was originally developed for sanitizing high-care production facilities in the food industry and is currently being used by some of Europe's largest food manufactures to control potentially harmful bacteria and contaminants.

"The technology behind our hygiene system has proven extremely effective at killing bacteria, molds and spoilage agents in the food industry,” said Peter Townley, managing director of Steritrox. "It is expected that the development project and field trial program will be complete in 12 months time. We hope we will then have developed an effective weapon to be deployed in the fight against the growing threat of hospital super bugs, as well as providing a credible defense process against similar attacks in the future.”



Related Links:
Steritrox

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.